The Impact of Genomic Changes on Treatment of Lung CancerCARDARELLA, Stephanie; JOHNSON, Bruce E.American journal of respiratory and critical care medicine. 2013, Vol 188, Num 7, pp 770-775, issn 1073-449X, 6 p.Article

Preoperative Evaluation of the Gynecologic Patient : Considerations for Improved OutcomesJOHNSON, Bruce E; PORTER, Joann.Obstetrics and gynecology (New York. 1953). 2008, Vol 111, Num 5, pp 1183-1194, issn 0029-7844, 12 p.Article

Management of small cell lung cancerJOHNSON, Bruce E.Clinics in chest medicine. 2002, Vol 23, Num 1, issn 0272-5231, x, 225-239 [15 p.]Article

Biomarkers of Response to Epidermal Growth Factor Receptor Inhibitors in Non-Small-Cell Lung Cancer Working Group : Standardization for Use in the Clinical Trial SettingEBERHARD, David A; GIACCONE, Giuseppe; JOHNSON, Bruce E et al.Journal of clinical oncology. 2008, Vol 26, Num 6, pp 983-994, issn 0732-183X, 12 p.Article

Epidermal growth factor receptor mutations in patients with non-small cell lung cancerJOHNSON, Bruce E; JÄNNE, Pasi A.Cancer research (Baltimore). 2005, Vol 65, Num 17, pp 7525-7529, issn 0008-5472, 5 p.Article

A model to select regimens for Phase III trials for patients with advanced-stage non-small cell lung cancerFREIDLIN, Boris; BREATHNACH, Oscar S; JOHNSON, Bruce E et al.Clinical cancer research. 2003, Vol 9, Num 3, pp 917-922, issn 1078-0432, 6 p.Article

Basic treatment considerations using chemotherapy for patients with small cell lung cancerJOHNSON, Bruce E; JÄNNE, Pasi A.Hematology/oncology clinics of North America. 2004, Vol 18, Num 2, pp v-vi, issn 0889-8588, 16 p.Article

Small-cell lung cancerJACKMAN, David M; JOHNSON, Bruce E.Lancet (British edition). 2005, Vol 366, Num 9494, pp 1385-1396, issn 0140-6736, 12 p.Article

Clinical, Pathologic, and Biologic Features Associated with BRAF Mutations in Non―Small Cell Lung CancerCARDARELLA, Stephanie; OGINO, Atsuko; NISHINO, Mizuki et al.Clinical cancer research (Print). 2013, Vol 19, Num 16, pp 4532-4540, issn 1078-0432, 9 p.Article

Radiographic assessment and therapeutic decisions at RECIST progression in EGFR-mutant NSCLC treated with EGFR tyrosine kinase inhibitorsNISHINO, Mizuki; CARDARELLA, Stephanie; DAHLBERG, Suzanne E et al.Lung cancer. 2013, Vol 79, Num 3, pp 283-288, issn 0169-5002, 6 p.Article

Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung CancerHAMMERMAN, Peter S; JÄNNE, Pasi A; JOHNSON, Bruce E et al.Clinical cancer research (Print). 2009, Vol 15, Num 24, pp 7502-7509, issn 1078-0432, 8 p.Article

First-Line Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Somatic EGFR MutationsSEQUIST, Lecia V; MARTINS, Renato G; KUHLMANN, Georgiana L et al.Journal of clinical oncology. 2008, Vol 26, Num 15, pp 2442-2448, issn 0732-183X, 7 p.Article

A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancerGANDHI, Leena; HARDING, Matthew W; NEUBAUER, Marcus et al.Cancer. 2007, Vol 109, Num 5, pp 924-932, issn 0008-543X, 9 p.Article

LKB1 modulates lung cancer differentiation and metastasisHONGBIN JI; RAMSEY, Matthew R; LIANG, Mei-Chih et al.Nature (London). 2007, Vol 448, Num 7155, pp 807-810, issn 0028-0836, 4 p.Article

Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non-small cell lung cancerHERBST, Roy S; DAVIES, Angela M; DE VRIES, Daniel J et al.Clinical cancer research. 2007, Vol 13, Num 20, pp 6175-6181, issn 1078-0432, 7 p.Article

Epidermal growth factor receptor mutation testing in the care of lung cancer patientsSEQUIST, Lecia V; JOSHI, Victoria A; VERLANDER, Peter et al.Clinical cancer research. 2006, Vol 12, Num 14, issn 1078-0432, 4403s-4408s, 2Conference Paper

Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapyWIRTH, Lori J; CARTER, Mark R; JÄNNE, Pasi A et al.Lung cancer. 2004, Vol 44, Num 2, pp 213-220, issn 0169-5002, 8 p.Article

Expression of bcl-2 protein is associated with shorter survival in nonsmall cell lung carcinomaHUANG, Chris I; NEUBERG, Donna; JOHNSON, Bruce E et al.Cancer. 2003, Vol 98, Num 1, pp 135-143, issn 0008-543X, 9 p.Article

Inhibition of epidermal growth factor receptor signaling in malignant pleural mesotheliomaJÄNNE, Pasi A; TAFFARO, Michele L; SALGIA, Ravi et al.Cancer research (Baltimore). 2002, Vol 62, Num 18, pp 5242-5247, issn 0008-5472, 6 p.Article

Making Personalized Cancer Medicine a Reality: Challenges and Opportunities in the Development of Biomarkers and Companion DiagnosticsPARKINSON, David R; JOHNSON, Bruce E; SLEDGE, George W et al.Clinical cancer research (Print). 2012, Vol 18, Num 3, pp 619-624, issn 1078-0432, 6 p.Article

Therapeutic targeting of multiple signaling pathways in malignant pleural mesotheliomaMUKOHARA, Toru; CIVIELLO, Gabriel; JOHNSON, Bruce E et al.Oncology. 2005, Vol 68, Num 4-6, pp 500-510, issn 0030-2414, 11 p.Article

Chemotherapy for locally advanced and metastatic pulmonary carcinoid tumorsCHONG, Curtis R; WIRTH, Lori J; NISHINO, Mizuki et al.Lung cancer. 2014, Vol 86, Num 2, pp 241-246, issn 0169-5002, 6 p.Article

Evaluation of Statistical Designs in Phase I Expansion Cohorts: The Dana-Farber/Harvard Cancer Center ExperienceDAHLBERG, Suzanne E; SHAPIRO, Geoffrey I; CLARK, Jeffrey W et al.Journal of the National Cancer Institute. 2014, Vol 106, Num 7, issn 0027-8874, dju163.1-dju163.6Article

Comparative Effectiveness of Three Platinum-Doublet Chemotherapy Regimens in Elderly Patients With Advanced Non-Small Cell Lung CancerJUNYA ZHU; SHARMA, Dhruv B; CHEN, Aileen B et al.Cancer. 2013, Vol 119, Num 11, pp 2048-2060, issn 0008-543X, 13 p.Article

Volumetric Tumor Growth in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutations During EGFR-Tyrosine Kinase Inhibitor Therapy: Developing Criteria to Continue Therapy Beyond RECIST ProgressionNISHINO, Mizuki; DAHLBERG, Suzanne E; CARDARELLA, Stephanie et al.Cancer. 2013, Vol 119, Num 21, pp 3761-3768, issn 0008-543X, 8 p.Article